Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/38092
Title: EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on valvular heart disease and the European Association of Cardiovascular Imaging endorsed cby the Heart Rhythm Society, by the Asia Pacific Heart Rhythm Society, and by the Latin American Heart Rhythm Society
Authors: Sabbag, Avi
Essayagh, Benjamin
Barrera, Juan David Ramirez
Basso, Cristina
Berni, Ana
Cosyns, Bernard
Deharo, Jean Claude
Deneke, Thomas
Di Biase, Luigi
Enriquez-Sarano, Maurice
Donal, Erwan
Imai, Katsuhiko
Lim, Han S.
Marsan, Nina Ajmone
Turagam, Mohit K.
Peichl, Petr
Po, Sunny S.
Haugaa, Kristina Hermann
Shah , Dipen
de Riva Silva, Marta
BERTRAND, Philippe 
Saba, Magdi
Dweck, Marc
Townsend, Santiago Nava
Ngarmukos, Tachapong
Fenelon, Guilherme
Santangeli, Pasquale
Sade, Leyla Elif
Corrado, Domenico
Lambiase, Pier
Sanders, Prashanthan
Delacretaz, Etienne
Jahangir , Arshad
Kaufman, Elizabeth S.
Saggu, Daljeet Kaur
Pierard, Luc
Delgado, Victoria
Lancellotti, Patrizio
Issue Date: 2022
Publisher: OXFORD UNIV PRESS
Source: Europace (London, England), 24 (12), p. 1981-2003
Abstract: Purpose of Review The present article reviews the role of multimodality imaging to improve risk stratification and timing of intervention in patients with valvular heart disease (VHD), and summarizes the latest developments in transcatheter valve interventions. Recent Findings Growing evidence suggests that intervention at an earlier stage may improve outcomes of patients with significant VHD. Multimodality imaging, including strain imaging and tissue characterization with cardiac magnetic resonance imaging, has the ability to identify early markers of myocardial damage and can help to optimize the timing of intervention. Transcatheter interventions play an increasing role in the treatment of patients who remain at high surgical risk or present at a late stage of their disease. Summary Multimodality imaging identifies markers of cardiac damage at an early stage in the development of VHD. Together with technological innovations in the field of percutaneous valvular devices, these developments have the potential to improve current management and outcomes of patients with significant VHD.
Notes: Sabbag, A (corresponding author), Davidai Ctr Rhythm Disturbances & Pacing, Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel.
avisabbag@gmail.com
Keywords: Mitral valve prolapse;Mitral annular disjunction;Sudden cardiac death;Ventricular arrhythmia;Risk stratification
Document URI: http://hdl.handle.net/1942/38092
ISSN: 1099-5129
e-ISSN: 1532-2092
DOI: 10.1093/europace/euac125
ISI #: 000838798800001
Rights: The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please email: journals.permissions@oup.com. Free access
Category: A1
Type: Journal Contribution
Validations: ecoom 2023
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
EHRA expert consensus statement on.pdfPublished version1.28 MBAdobe PDFView/Open
Show full item record

WEB OF SCIENCETM
Citations

57
checked on Mar 29, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.